Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-09-25A Phase II Study of Anti-PD1 Monoclonal Antibody (Nivolumab, BMS-936558) Administered in Combination with Anti-LAG3 Monoclonal Antibody (Relatlimab, BMS-986016) in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting
-
CLINICAL_TRIALS study record update · 2024-09-25Multicenter, Prospective Study to Examine Pigmented, Non-pigmented, Tumorous and Inflammatory Lesions of the Skin With Regard to Cut Margin Control, Differentiation, Grading and Tumor Thickness Using Confocal Laser Microscopy
-
CLINICAL_TRIALS study record update · 2024-09-23Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma Eligible for Lymph Node Sentinel Biopsy (CORRESPOND): an Observational Prospective Study.
-
CLINICAL_TRIALS study record update · 2024-09-20Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
-
CLINICAL_TRIALS study record update · 2024-09-19A Randomized, Single-center, Open-label, Single Dose, Two-period, Crossover Pivotal Bioequivalence Study Comparing Binimetinib 3 x 15 mg and 45 mg Tablets in Healthy Participants
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase 1/2A Trial of ENB 003 in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-09-19Use of Hydrochlorothiazide and the Risk of Skin Cancer
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase I Trial of PVSRIPO for Patients With Unresectable Melanoma
-
CLINICAL_TRIALS study record update · 2024-09-05Immunotherapy Multi-omics Specimen Protocol A
-
CLINICAL_TRIALS study record update · 2024-09-04Exploring the Utility of a Novel BRAF Test in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2024-08-26Stereotactic Body Radiotherapy in Addition to Standard of Care Treatment in Patients With Rare Oligometastatic Cancers (OligoRARE): a Randomized, Phase 3, Open-label Trial
-
CLINICAL_TRIALS study record update · 2024-08-22Primary Ipilimumab and Nivolumab Combo-immunotherapy Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2024-08-21Immune Checkpoint Inhibitors and Carbon iON Radiotherapy In Solid Cancers With Stable Disease
-
CLINICAL_TRIALS study record update · 2024-08-21A Phase IB Study of Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Stimulating Factor
-
CLINICAL_TRIALS study record update · 2024-08-16A Phase 1, First-in-Human, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Immunogenetic and Efficacy of RC198 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-08-15BESPOKE Study of ctDNA Guided Immunotherapy
-
CLINICAL_TRIALS study record update · 2024-08-15A Double Blind Randomised Phase 2 Trial of Docetaxel With or Without AZD6244 in wt BRAF Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2024-08-12Phase 2 Study of Denosumab in Combination With a PD-1 Inhibitor in Subjects With Stage III/IV Melanoma
-
CLINICAL_TRIALS study record update · 2024-08-02Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer
-
CLINICAL_TRIALS study record update · 2024-07-31A Phase I/II Study of MCS110 With BRAF/MEK Inhibition in Patients With Melanoma After Progression on BRAF/MEK Inhibition
-
CLINICAL_TRIALS study record update · 2024-07-24A Phase 1/2a Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab Administered in Combination With Ipilimumab or Ipilimumab Alone in Participants With Unresectable or Metastatic Melanoma Who Have Progressed on Anti-PD-1 Therapy
-
CLINICAL_TRIALS study record update · 2024-07-22A Phase IIB, Open Label, Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies, Scheduled to Receive Immunotherapy (IOT) as a Single Agent or Combination, to Predict Response to Therapy
-
CLINICAL_TRIALS study record update · 2024-07-19A First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patients With Advanced Tumors
-
CLINICAL_TRIALS study record update · 2024-07-17A Phase I/II Study of LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2024-07-17QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.